Novartis AG provided earnings guidance for the year 2024. For the year, net sales expected to grow mid single digit and core operating income expected to grow high single digit.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.9 CHF | -0.20% |
|
+1.86% | +16.53% |
Jul. 15 | Brace for a flurry of speeches from Fed officials | ![]() |
Jul. 15 | European companies cut jobs as economy sputters | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.53% | 226B | |
+62.69% | 856B | |
+38.95% | 631B | |
-3.85% | 359B | |
+16.11% | 325B | |
+8.92% | 297B | |
+5.89% | 234B | |
+15.71% | 177B | |
+1.96% | 165B | |
+2.41% | 126B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis AG Provides Earnings Guidance for the Year 2024